Skip Over Navigation Links
National Institutes of Health

Science News about Anxiety Disorders

Find Science News by Topic

Or Find Science News by Year

2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002

Science News about Anxiety Disorders

New Silvio O. Conte Centers Address Brain Development, Disorders
March 18, 2009 • Science Update
With a mandate to use innovative, multidisciplinary research approaches to address important mental health questions, four newly funded centers have begun investigations of schizophrenia, brain development, and adolescent mood disorders.
Anxious and Depressed Teens and Adults: Same Version of Mood Gene, Different Brain Reactions
December 02, 2008 • Science Update
An NIMH study using brain imaging shows that some anxious and depressed adolescents react differently from adult patients when looking at frightening faces.
Cells May Provide Target for New Anxiety Medications
November 06, 2008 • Science Update
A specific population of brain cells could provide a target for developing new medications aimed at helping people learn to mute the fears underlying anxiety disorders, according to NIMH-supported scientists.
Anxious and Healthy Adolescents Respond Differently to an Anxiety-provoking Situation
November 05, 2008 • Science Update
Brain scans show heightened activity among anxious adolescents exposed to an anxiety-provoking situation when compared with normal controls, according to an NIMH study published in the November 2008 issue of the Archives of General Psychiatry.
Study Identifies Three Effective Treatments for Childhood Anxiety Disorders
October 30, 2008 • Press Release
Treatment that combines a certain type of psychotherapy with an antidepressant medication is most likely to help children with anxiety disorders, but each of the treatments alone is also effective.
Emotion-Regulating Circuit Weakened in Borderline Personality Disorder
October 02, 2008 • Science Update
Differences in the working tissue of the brain, called grey matter, have been linked to impaired functioning of an emotion-regulating circuit in patients with borderline personality disorder (BPD).
Anxious Youth Have Disturbed Brain Responses When Looking at Angry Faces
June 20, 2008 • Science Update
When looking at angry faces so quickly that they are hardly aware of seeing them, youth with generalized anxiety disorder (GAD) have unchecked activity in the brain’s fear center, say NIMH researchers.
Imaging Identifies Brain Regions and Chemicals Underlying Mood Disorders; May Lead to Better Treatments
May 06, 2008 • Science Update
WASHINGTON, DC, May 6 — Recently developed imaging techniques allow the mapping of the brain circuits and chemical systems believed responsible for a range of mood abnormalities including depression and bipolar disorder, and hold promise for improved treatments, scientists say.
Medication-Enhanced Learning in Therapy Hailed as “Paradigm Shift” for Anxiety
May 01, 2008 • Science Update
A medication that enhances learning, taken just before an exposure therapy session, may aid cognitive behavior therapy (CBT) for anxiety disorders, say NIMH-funded researchers, who adapted the technique from studies in rats.
Human Brain Appears “Hard-Wired” for Hierarchy
April 23, 2008 • Press Release
Human imaging studies have for the first time identified brain circuitry associated with social status, according to researchers at the National Institute of Mental Health (NIMH) of the National Institutes of Health. They found that different brain areas are activated when a person moves up or down in a pecking order – or simply views perceived social superiors or inferiors. Circuitry activated by important events responded to a potential change in hierarchical status as much as it did to winning money.
Journal Highlights Effectiveness of Research Based Psychotherapies for Youth
April 15, 2008 • Science Update
Reviews of the current research on psychosocial and behavioral therapies, or psychotherapies, for children and adolescents found a number of "well established" and "probably efficacious" treatments for many mental disorders. For example, six were "probably efficacious" for anxiety disorders, and two were "well established" for attention deficit hyperactivity disorder (ADHD), according to scientists funded by NIMH and the National Institute on Drug Abuse, divisions of the National Institutes of Health.
Co-occurring Anxiety Complicates Treatment Response for Those with Major Depression
February 25, 2008 • Science Update
People with major depression accompanied by high levels of anxiety are significantly less likely to benefit from antidepressant medication than those without anxiety, according to a study based on data from the NIMH-funded Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. The study was published online ahead of print in January 2008, in the American Journal of Psychiatry.
Tomorrow’s Antidepressants: Skip the Serotonin Boost?
February 14, 2008 • Science Update
New research adds to evidence of potentially better molecular targets in the brain to treat depression and other mental disorders, according to NIMH-funded scientists.
Behavioral Therapy Effectively Treats Children with Social Phobia
December 17, 2007 • Science Update
A behavioral therapy designed to treat children diagnosed with social phobia helped them overcome more of their symptoms than the antidepressant fluoxetine (Prozac).
New Social Neuroscience Grants to Help Unravel Autism, Anxiety Disorders
October 10, 2007 • Science Update
How genes and the environment shape the brain circuitry underlying social behavior is among the questions being addressed by three newly NIMH-funded studies.
New Study Will Examine Effects of Excluding Anti-anxiety Medications in Medicare Part D Coverage
June 22, 2007 • Science Update
A new research grant funded by NIMH will examine the costs and benefits of excluding a commonly prescribed class of anti-anxiety medications—benzodiazepines—from coverage in the new Medicare Part D program. Medicare Part D, the prescription drug coverage plan for people insured by Medicare, went into effect in January 2006.
Half of Adults With Anxiety Disorders Had Psychiatric Diagnoses in Youth
February 07, 2007 • Science Update
About half of adults with an anxiety disorder had symptoms of some type of psychiatric illness by age 15, a NIMH-funded study shows.
Mouse Model May Reveal Anxiety Gene, Marker for Antidepressant Failure
November 09, 2006 • Science Update
Studies of a new mouse model suggest that a specific gene variation plays a role in the development of anxiety disorders and in resistance to common medications for anxiety and depression.
Obesity Linked with Mood and Anxiety Disorders
July 03, 2006 • Science Update
Results of an NIMH-funded study show that nearly one out of four cases of obesity is associated with a mood or anxiety disorder, but the causal relationship and complex interplay between the two is still unclear.
Intermittent Explosive Disorder Affects up to 16 Million Americans
June 05, 2006 • Press Release
A little-known mental disorder marked by episodes of unwarranted anger is more common than previously thought, a study funded by NIMH has found.
Gene Knockout Scores a Fearless Mouse
November 22, 2005 • Press Release
Knocking out a gene in the brain's fear hub creates mice unperturbed by situations that would normally trigger instinctive or learned fear responses, researchers funded, in part, by the National Institutes of Health have discovered.
Rat Brain’s Executive Hub Quells Alarm Center if Stress is Controllable
February 11, 2005 • Press Release
Treatments for mood and anxiety disorders are thought to work, in part, by helping patients control the stresses in their lives.
Creation of New Neurons Critical to Antidepressant Action in Mice
August 07, 2003 • Press Release
Blocking the formation of neurons in the hippocampus blocks the behavioral effects of antidepressants in mice, say researchers funded by the National Institutes of Health (NIH).
NIMH Awards Howard University $6.5 Million
January 25, 2002 • Press Release
Howard University Hospital Department of Psychiatry in the College of Medicine (HUCM) has been awarded $6.5 million from the National Institute of Mental Health (NIMH) for a five-year project to implement and develop research studies pertaining to mood and anxiety disorders.